Abstract
Treatment strategies against acute neuroleptic-induced akathisia (NIA) include anticholinergic (antimuscarinic) agents, dopamine agonists, GABAergic agents, beta-blockers, benzodiazepines, and serotonin antagonists. However, many patients who have acute akathisia fail to respond. In previous studies, mianserin and vitamin B6 were found to be effective in the treatment of acute akathisia. The purpose of this study was to compare the efficacy of B(6), mianserin and placebo in the treatment of acute NIA. Sixty schizophrenia and schizoaffective inpatients who have NIA were randomly divided to receive vitamin B(6) 1,200 mg/d, mianserin 15 mg/d, or placebo for 5 days, in a double-blind design. The Barnes Akathisia Rating Scale, Brief Psychiatric Rating Scale, and Clinical Global Impression were used to assess the severity of NIA and psychotic symptoms. The assessment was made at baseline and daily for the duration of the study. Compared with the placebo group, the vitamin B(6)-treated and mianserin-treated patients showed a significant improvement in the subjective (P < 0.0001), subjective distress (P < 0.0001), and global (P < 0.0001) subscales. The objective subscale did not show significant positive results (P = 0.056), but there ...Continue Reading
References
Feb 1, 1990·Journal of Clinical Psychopharmacology·W W FleischhackerJ M Kane
Jan 1, 1990·Psychopharmacology·D J Greenblatt, V H Sethy
Jun 1, 1990·The International Journal of Neuroscience·R Sandyk, R Pardeshi
Jan 1, 1989·Psychopharmacology·L A AdlerJ Rotrosen
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Sep 1, 1985·Archives of General Psychiatry·T R Barnes, W M Braude
Sep 1, 1985·Archives of General Psychiatry·S M Stahl
Jun 1, 1987·The American Journal of Psychiatry·B DupuisH Petit
Jan 1, 1995·Schizophrenia Bulletin·P Sachdev
Feb 15, 1994·Biological Psychiatry·P Sachdev
Apr 1, 1996·The American Journal of Psychiatry·S Kapur, G Remington
Oct 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·D WeissA Weizman
Aug 1, 1997·Journal of Autism and Developmental Disorders·R L FindlingM Wiznitzer
Jun 9, 1998·Journal of Clinical Psychopharmacology·M PoyurovskyA Weizman
Dec 9, 1998·Biochemistry and Molecular Biology International·L CabriniB Tolomelli
Dec 23, 1998·The Journal of Clinical Psychiatry·V Lerner, M Liberman
Aug 17, 1999·The British Journal of Psychiatry : the Journal of Mental Science·M PoyurovskyA Weizman
Jul 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M Poyurovsky, A Weizman
Sep 5, 2001·The American Journal of Psychiatry·V LernerM Kotler
Sep 5, 2001·The British Journal of Psychiatry. Supplement·R M Hirschfeld
Jan 5, 2002·Journal of Clinical Psychopharmacology·T FischelA Weizman
Jun 22, 2002·International Journal of Psychiatry in Medicine·Chanoch MiodownikVladimir Lerner
Oct 31, 2002·Human Psychopharmacology·Lars Hansen
Nov 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Jennifer HallidayRobin McCreadie
Nov 12, 2003·Schizophrenia Bulletin·Shigehiro Hirose
Dec 4, 2003·Clinical Neuropharmacology·Jong-Hoon Kim, Hee-Jung Byun
Nov 24, 2004·The Journal of Clinical Psychiatry·Vladimir LernerChanoch Miodownik
Citations
Feb 15, 2007·Current Treatment Options in Neurology·Shu-Ching Hu, Steven J Frucht
Jan 16, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sutton MooneyHanjo Hellmann
Dec 12, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Task force on Treatment Guidelines for Schizophrenia
Jul 5, 2013·The International Journal of Neuropsychopharmacology·Taro Kishi, Nakao Iwata
Nov 30, 2013·The International Journal of Neuropsychopharmacology·Zacharias G Laoutidis, Christian Luckhaus
May 4, 2016·Therapeutic Advances in Psychopharmacology·Musa U UmarAsmaul H Abba
Feb 3, 2007·Clinical Neuropharmacology·Chanoch MiodownikJoseph Levine
Jul 22, 2009·Clinical Neuropharmacology·Jong-Hoon Kim, Min-Jung Kim
May 18, 2010·Journal of Clinical Psychopharmacology·Ashish AggarwalRam C Jiloha
Aug 2, 2008·Clinical Neuropharmacology·Chanoch MiodownikVladimir Lerner
May 10, 2013·Harvard Review of Psychiatry·David N OsserTheo Manschreck
Dec 18, 2019·Psychiatry and Clinical Neurosciences·Natalie SeilerBrian O'Donoghue
Jan 27, 2018·The Journal of Nervous and Mental Disease·H J Rogier HoendersJoop T V M de Jong
Jun 5, 2020·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Stephana J CherakTanis R Fenton
Sep 15, 2020·Therapeutic Advances in Psychopharmacology·Shaina MuscoIan Caudle
Feb 17, 2017·Psychological Medicine·J FirthA R Yung
Apr 25, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tamara PringsheimThomas R E Barnes
Aug 22, 2018·Der Nervenarzt·D HirjakR C Wolf
Oct 13, 2020·Journal of Clinical Psychopharmacology·Narges Shams-AlizadehKambiz Hassanzadeh
Aug 15, 2021·Neuropsychopharmacology Reports·UNKNOWN Japanese Society of Neuropsychopharmacology
Oct 26, 2018·Neuropsychobiology·Monique AucoinSean Kidd